Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2004
05/06/2004EP1326836B1 Process for making 3-amino-2-chloro-4-methylpyridine
05/06/2004EP1036072B1 Thrombin receptor antagonists
05/06/2004CA2503462A1 Selected cgrp antagonists, processes for preparing them and their use aspharmaceutical compositions
05/06/2004CA2503455A1 Selected cgrp antagonists, method for production and use thereof as medicament
05/06/2004CA2502488A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
05/06/2004CA2500974A1 Nuclear hormone receptor compounds, products and methods employing same
05/05/2004CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
05/05/2004CN1494422A Use of GABAA inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin E for treatment of cognitive disorders
05/05/2004CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase
05/05/2004CN1148370C Technology for preparing oxymatrine from sophora alopecuroide
05/05/2004CN1148369C 1,8-naphthyridine derivatives
05/05/2004CN1148361C Oxyiminoalkanoic acid derivatives
05/04/2004US6730789 Radiation resistance, weatherproof, washfastness, colorfastness; hair dyes
05/04/2004US6730788 Process for 1,10-phenanthroline ligands
05/04/2004US6730682 Herpes virus
05/04/2004US6730675 Such as 7-chloro-4-hydroxy-2-(2,5-dimethyl(3-furanyl)) methyl-1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-dione which binds nmda receptors (n-methyl-aspartic acid receptors); neuropathy
05/04/2004CA2119756C Process for preparing benzo[b]naphtyridines
04/2004
04/29/2004WO2004035582A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same
04/29/2004WO2004035581A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
04/29/2004WO2004035580A1 Reactivation of wild type p53 in human tumour cells by a low molecular weight compound
04/29/2004WO2004035579A1 Imidazopyridine derivative, process for producing the same, and use
04/29/2004WO2004035578A1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines
04/29/2004WO2004035577A2 Pre-organized tricyclic integrase inhibitor compounds
04/29/2004WO2004035576A2 Pre-organized tricyclic integrase inhibitor compounds
04/29/2004WO2004035573A1 Method for preparing risperidone
04/29/2004WO2004035569A2 Novel compounds with antibacterial activity
04/29/2004WO2004035564A1 Pyridine derivatives useful as herbicides
04/29/2004WO2004035563A1 3-heterocyclylpyridine derivatives useful as herbicides
04/29/2004WO2004035550A1 Novel bicyclic inhibitors of hormone sensitive lipase
04/29/2004WO2004035549A1 Benzimidazole derivatives and their use as vanilloid receptor ligands
04/29/2004WO2004035543A1 Tetrahydroquinoline derivatives as crth2 antagonists
04/29/2004WO2004035536A2 Azo compounds for type i phototherapy
04/29/2004WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
04/29/2004WO2004034983A2 Preparation of triazospiro compounds
04/29/2004WO2004034972A2 Compounds, compositions, and methods
04/29/2004WO2004016086A3 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
04/29/2004WO2004014906A3 Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
04/29/2004WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors
04/29/2004WO2004013139A3 Process for preparing 7-azaindoles
04/29/2004WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions
04/29/2004WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
04/29/2004WO2003074524A3 Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
04/29/2004WO2003028459A8 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
04/29/2004WO2002085909A8 9-deazaguanine derivatives as inhibitors of gsk-3
04/29/2004WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications
04/29/2004US20040082790 Piperidine amides as modulators of chemokine receptor activity
04/29/2004US20040082788 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof
04/29/2004US20040082787 Chemical compounds
04/29/2004US20040082784 Anxiolytic agents; antidepressants; Alzheimer, Huntington, Parkinson disease
04/29/2004US20040082781 Bicyclic nitrogenous fused-ring compound
04/29/2004US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof
04/29/2004US20040082778 Amination process
04/29/2004US20040082635 Fused cyclic compounds and medicinal use thereof
04/29/2004US20040082631 Pyrazole compositions useful as inhibitors of ERK
04/29/2004US20040082625 Osteoporosis, bone disorders
04/29/2004US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor
04/29/2004US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases
04/29/2004US20040082605 Use
04/29/2004US20040082604 Antiarthritic agents; osteoporosis; immunosuppressants; antiinflammatory agents; autoimmunology diseases
04/29/2004US20040082603 2,3-Dihydro-isoindol-1-one derivatives
04/29/2004US20040082596 Novel carbamate-substituted pyrazolopyridine derivatives
04/29/2004US20040082592 Metabotropic glutamate receptor antagonists
04/29/2004US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders
04/29/2004US20040082584 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease
04/29/2004US20040082583 Chemical compounds
04/29/2004US20040082573 Anxiolytic agents with reduced sedative and ataxic effects
04/29/2004US20040082563 Thrombosis therapy; antitumor agents; anticoagulants; Factor x inhibitors; anticholesterol agents; cardiovascular disorders; antiinflammatory agents
04/29/2004US20040082562 Novel inhibitors of IMPDH enzyme
04/29/2004US20040082555 Use of gaba, inverse agonists in combination with nicotine receptor partial agonist, estrogen, selective estrogen modulators, or vitamin E for the treatment of cognitive disorders
04/29/2004CA2502515A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same
04/29/2004CA2502211A1 Azo compounds for type i phototherapy
04/29/2004CA2501881A1 Pre-organized tricyclic integrase inhibitor compounds
04/29/2004CA2501798A1 Preparation of triazospiro compounds
04/29/2004CA2501539A1 Benzimidazole derivatives and their use as vanilloid receptor ligands
04/29/2004CA2500320A1 Novel compounds with antibacterial activity
04/29/2004CA2500083A1 Tetrahydroquinoline derivatives as crth2 antagonists
04/29/2004CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
04/28/2004EP1413553A1 Synthesis of itq-17 in the absence of fluoride ions
04/28/2004EP1413306A1 Tetrahydroquinoline derivatives as CRTH2 antagonists
04/28/2004EP1412360A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE
04/28/2004EP1412354A1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS
04/28/2004EP1412353A1 Imidazopyridinones as p38 map kinase inhibitors
04/28/2004EP1412352A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands
04/28/2004EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
04/28/2004EP1412078A1 Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof
04/28/2004EP1411949A2 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
04/28/2004EP1411942A1 Substituted anilinic piperidines as mch selective antagonists
04/28/2004EP1411940A1 Bridged piperidine derivatives as melanocortin receptor agonists
04/28/2004EP1411939A2 Gaba a-receptor-modulators having nmda-antagonistic activity
04/28/2004EP1411928A1 Viral polymerase inhibitors
04/28/2004EP1289986B1 1,4-diazabicyclo 3.2.2]nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
04/28/2004EP1261608B1 Diketopiperazine derivatives to inhibit thrombin
04/28/2004EP0971922B1 Tetrahydropyrido compounds
04/28/2004CN1492869A Tricyclic androgen receptor modulator compounds and method
04/28/2004CN1492868A Quinuclidine carbamate derivatives and their use as m3 antigonists
04/28/2004CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor
04/28/2004CN1491944A 5-amino-8-methoxy quinolone carboxylic acid derivatives and its preparation
04/28/2004CN1491941A Heterobicyclic sulfonamide derivative and sulfonic ester derivative
04/28/2004CN1147489C New bicyclo aminopyrazineone compound, its production process and medical composition containing them
04/28/2004CN1147487C Racemization of R,S-dioxo-benzyl pyrrolopiperidine